KEGG   DRUG: Empagliflozin and metformin
Entry
D10752            Mixture   Drug                                   
Name
Empagliflozin and metformin;
Synjardy (TN)
Product
SYNJARDY (Boehringer Ingelheim Pharmaceuticals), SYNJARDY (Boehringer Ingelheim Pharmaceuticals)
Component
Empagliflozin [DR:D10459], (Metformin hydrochloride [DR:D00944] | Metformin [DR:D04966])
Class
Antidiabetic agent
 DG02044  Hypoglycemic agent
  DG03034  Combination of metformin and SGLT2 inhibitor
Remark
ATC code: A10BD20
Product: D10752<US>
Efficacy
Antidiabetic
  Disease
Type 2 diabetes mellitus [DS:H00409]
Interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 A ALIMENTARY TRACT AND METABOLISM
  A10 DRUGS USED IN DIABETES
   A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
    A10BD Combinations of oral blood glucose lowering drugs
     A10BD20 Metformin and empagliflozin
      D10752  Empagliflozin and metformin <US>
USP drug classification [BR:br08302]
 Blood Glucose Regulators
  Antidiabetic Combinations
   Empagliflozin/ Metformin Hydrochloride
    D10752  Empagliflozin and metformin
Drug groups [BR:br08330]
 Antidiabetic agent
  DG02044  Hypoglycemic agent
   DG03034  Combination of metformin and SGLT2 inhibitor
    D10752  Empagliflozin and metformin
Drug classes [BR:br08332]
 Antidiabetic agent
  DG02044  Hypoglycemic agent
   D10752  Empagliflozin and metformin
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D10752
Other DBs
PubChem: 273220348
ChEBI: 90875
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system